UV Infection Control Devices Market Study by Current and Upcoming Trends, Opportunities, Size, Trends and Forecast 2026
Pune, Maharashtra, India, September 15 2020 (Wiredrelease) Allied Analytics –:The Global UV infection control devices market size was valued at $317 million in 2018, and is projected to reach $525 million by 2026, registering a CAGR of 6.5% from 2019 to 2026.
UV infection control devices emit ultraviolet rays that can kill infection causing microorganisms present in various healthcare facilities such as hospitals, clinics, and others. Furthermore, there are different types of UV infection control devices available in the market. For instance, mobile UV infection control devices are portable and can be moved from one place to another easily. In addition, the devices have handles all around which aid in the movement of device from one location to another. However, station type UV infection control devices are designed to plug into a standard power outlet. Moreover, these devices work by reflecting UV light off the walls. This reflected light is then absorbed by bacteria, whose light-sensitive porphyrin molecules become excited and, as a result, experience oxidative damage and cell death.
Download Free Sample Report @ https://www.alliedmarketresearch.com/request-sample/6472
Focus of governments on infection control programs, surge in prevalence of hospital acquired infections (HAI), and increase in adoption of technologically advanced UV equipment drive the growth of the global UV infection control devices market. However, high costs and strict government regulations hinder the market growth. On the other hand, untapped potential in emerging countries create new opportunities in coming years.
The report offers a detailed segmentation of the global UV infection control devices market on the basis of type, end user, and region. Based on type, the mobile segment held more than two-fifths of the total market share in 2018, and is expected to maintain its lead position throughout the forecast period. Moreover, this segment is expected to maintain its fastest CAGR of 7.3% from 2019 to 2026. The research also analyzes segments including stationary and others.
Based on end user, the hospitals segment contributed to the highest share of the total market, accounting for nearly half of the global market in 2018, and is estimated to maintain its dominant position in terms of revenue by 2026. Moreover, this segment is estimated to register the fastest CAGR of 6.8% during the forecast period. The report also discusses segments including clinics and others.
Based on region, North America held the highest market share in terms of revenue, contributing to more than two-fifths of the total market share in 2018, and is estimated to maintain its highest share throughout the forecast period. However, Asia-Pacific is expected to witness the highest CAGR of 8.1% from 2019 to 2026. The research also analyzes segments including Europe and LAMEA.
For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/6472
Key players of the global UV infection control devices market analyzed in the research include CVS Health Corporation, Express Scripts Holding Company, DocMorris, Optum Rx Inc., Giant Eagle Inc., The Kroger Co., Rowlands Pharmacy, Walmart Stores Inc., Walgreen Co., and Apollo Pharmacy. They have adopted various strategies including collaborations, partnerships, mergers & acquisitions, new product launches, and others to gain a strong position in the industry.
This content has been published by Allied Analytics company. The WiredRelease News Department was not involved in the creation of this content. For press release service enquiry, please reach us at email@example.com.